Similarly, LAP peptides inhibiting the interaction between TGF-β and its receptor have been shown to decrease fibrosis, attenuate the activation of the TGF-β signaling pathway, and prevent left ventricular dilatation and dysfunction in mice subjected to isoproterenol exposure [63]. This evidence concerns the gene TGFB1 and Left ventricular dilatation.